Combined RAF1 protein expression and p53 mutational status provides a strong predictor of cellular radiosensitivity
2000

RAF1 Protein and p53 Status Predict Cellular Radiosensitivity

publication

Author Information

Author(s): Warenius H M, Jones M, Gorman T, McLeish R, Seabra L, Barraclough R, Rudland P

Primary Institution: Human Tumour Biology Group, University Clinical Departments, Oncology Research Unit, Department of Medicine, The University of Liverpool

Hypothesis

The study investigates how RAF1 protein expression and p53 mutational status affect cellular radiosensitivity.

Conclusion

The study found that RAF1 protein levels are strongly related to radiosensitivity in cells with wild-type p53, but not in those with mutant p53.

Supporting Evidence

  • Cell lines with mutant p53 were radioresistant and showed no relationship between RAF1 and radiosensitivity.
  • Cell lines with wild-type p53 showed a strong relationship between RAF1 levels and radiosensitivity.
  • Higher RAF1 levels in wild-type p53 cells were associated with shorter exit times from G2/M block.

Takeaway

This study shows that certain proteins can help predict how sensitive cancer cells are to radiation, which can help in treatment planning.

Methodology

The effects of RAF1 protein on cell cycle checkpoints and radiosensitivity were examined in human cell lines with different p53 statuses.

Digital Object Identifier (DOI)

10.1054/bjoc.2000.1409

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication